Bartosz Lukowski

3PUBLICATIONS
22CO-AUTHORS
Social epidemiologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 22, 2026
Bimekizumab 2-year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results.

|Jun 05, 2026
Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

|Jul 13, 2025
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.

Vivian Y Shi, John R Ingram, Hadar Lev-Tov

Pageof 1

Frequent Collaborators

2 joint publications

Hadar Lev-Tov

2 joint publications

Martina Lee Porter

2 joint publications

Koremasa Hayama

2 joint publications

Linnea Thorlacius